| Bioactivity | Glucosylceramide synthase-IN-4 (compound 12) is a potent glucosylceramide synthase (GCS) inhibitor, with an IC50 of 6.8 nM. Glucosylceramide synthase-IN-4 shows excellent PK properties and stability in human hepatocytes. Glucosylceramide synthase-IN-4 has good CNS penetration and acceptable PXR selectivity[1]. |
| Name | Glucosylceramide synthase-IN-4 |
| CAS | 2776965-41-2 |
| Formula | C22H18F5N3O3 |
| Molar Mass | 467.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. H. Marie Loughran, et al. Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections. ACS Med. Chem. Lett. 2024, 15, 1, 123-131. |
Glucosylceramide synthase-IN-4
CAS: 2776965-41-2 F: C22H18F5N3O3 W: 467.39
Glucosylceramide synthase-IN-4 (compound 12) is a potent glucosylceramide synthase (GCS) inhibitor, with an IC50 of 6.8
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.